Mills Lab
Cancer Research at Cold Spring Harbor Laboratory
Glioblastoma (GBM) has a median survival rate of just 12-15 months, with only about 5% of patients surviving 5 years after diagnosis.
Let’s change it.
Our lab’s mission is to understand GBM and other cancers to pave the way for better treatments.
Cutting-edge technologies.
Dr. Caizhi Wu, Research Associate, is performing molecular analyses to probe pathways that are deregulated in cancer. Our ability to combine multi-faceted approaches ranging from the atomic, molecular, genomic, cellular, genetic, and organismal level allows us to identify novel approaches for cancer treatment.
Changing the world.
Former Graduate student Heng Liang asks former postdoctoral fellow Dr. Sherine Sun for help on integrating genome-wide expression and chromatin accessibility data.
Collaboration is key.
Professor Mills is admiring the technique by which former Graduate Student Padmina Shrestha was able to establish neuronal cultures from embryonic brain, as this system is used to shed light on how epigenetic processes control cell fate decisions that shape the mammalian brain.
Diversity is essential.
We are an international group of team players. Here we are enjoying a celebratory lunch at Bistro Cassis to celebrate Seamus Balinth having received his doctoral degree.
“If you know you are on the right track, if you have this inner knowledge, then nobody can turn you off... no matter what they say.”
— Barbara McClintock